Inito Launches InSight Wireless Reader, the Most Precise At-Home Fertility Reader, Trained on Over 40M Datapoints

Audio By Carbonatix

HOUSTON--(BUSINESS WIRE)--Apr 9, 2026--

Inito, a technology company focused on at-home diagnostics, today announced the official launch of InSight Wireless Reader, a Wi-Fi enabled fertility hormone reader designed to deliver the most precise fertility hormone measurements from the comfort of home 1. Powered by patented Spectral Mapping technology, InSight Wireless Reader measures four key fertility hormones on a single fertility strip: estrogen (E3G), LH, PdG (a urine metabolite of progesterone), and FSH.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260409655970/en/

Inito InSight Wireless Reader

“When you’re trying to conceive, you don’t just want a result, you want to trust it,” said Aayush Rai, Co-Founder of Inito. “We built InSight Wireless Reader to raise the standard for at-home hormone tracking in two ways: by improving how hormone levels are measured, and by making testing work better in real life. Because when you’re tracking something this important, both precision and ease of use matter.”

Most at-home ovulation tests track only LH and provide a binary yes/no result. That may suggest ovulation is approaching, but it does not actually confirm it. In reality, fertility is a sequence of hormonal events across the cycle, not a single moment. Hormones rise, peak, fall, and sustain over time. Real understanding comes from seeing how those patterns change for a range of fertility journeys, including users with irregular cycles, PCOS-like conditions, post-pill, pre-IVF, and more.

Inito’s methodology is backed by peer-reviewed research and its accuracy validated in published studies. Inito’s hormone trends correspond closely with blood hormone trends, with 95% accuracy2, and a PdG-based method showed 92.2% precision in confirming ovulation among users testing at home. Built on this clinically validated foundation, the InSight Wireless Reader takes this precision further with our patented Spectral Mapping technology.

• Four hormones measured separately: Hormones are measured across four independent tracks on a single fertility strip, preventing cross-reactivity and cross-signal interference.
• Dual-signal verification: Each test is double checked using two sensing methods - fluorescence and visual colorimetric imaging allowing Inito to detect subtle hormone changes so that you don’t miss your fertile days.
• 100x richer signal: The entire surface of the strip is captured across time to generate a 100x richer signal from every test. That richer data helps our AI algorithm remove common real world variables such as lighting, humidity, etc., to deliver lab-grade reliability at home.

“As a physician, the most meaningful fertility conversations happen when we can review a patient’s full hormone pattern, not just a single lab result,” said Dr. Lora Shahine, Advisor at Inito. “Tools like the InSight Wireless Reader, which track hormone patterns across cycles, give patients accurate data so they can come into consultations feeling informed and confident. That full picture allows for quicker decisions and more timely adjustments to care, making it a meaningful step forward for anyone on their fertility journey.”

InSight Wireless Reader is built for real life. With built-in Wi-Fi, users can start a test, put their phone away, and receive results in the app when the test is complete.

InSight Wireless Reader is compatible with iOS and now Android for the first time, retailing at an introductory launch price of $99 with 15 Fertility Strips included. It is HSA/FSA eligible and can be purchased at Inito.com for shipments within the United States.

Imagery of Inito InSight Wireless Reader here

About Inito

Inito is a technology company focused on at-home diagnostics. Its flagship product is an at-home fertility monitor that deciphers hormone levels, confirms if you actually ovulate and gives people a better sense of what is happening inside their own body. Starting with fertility and expanding into areas like testosterone, vitamins, thyroid hormones, and more, Inito enhances how personal health is managed. With 20+ patents, a database of over 40 million fertility hormone tests, and a rapidly growing global team across Dubai, Bangalore, and London, Inito is committed to helping more people reach their life goals by putting lab-grade, biological insights in their hands. To learn more about Inito and how they are building the future of at-home health testing, visit https://www.inito.com.

1 ‘Most precise’ refers to system-level precision measured in controlled laboratory testing, based on lower between-device variability across key hormones, concentrations, operators, days, and strip lots. Compares Inito to other U.S. over-the-counter at-home fertility monitors that provide numeric or graded hormone values and measure the same hormones as Inito.

2 Accuracy may be reduced in irregular cycles, anovulatory cycles, or when hormone levels are affected by medical conditions, medications, or inconsistent testing. “95% accuracy to corresponding blood hormone trends” refers to published findings showing that Inito’s urinary hormone measurements closely matched the direction and pattern of corresponding serum hormone changes over time. It does not mean urine values are identical to blood values or that absolute urine and blood hormone numbers will match exactly.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260409655970/en/

CONTACT: Media contact:

Jack Taylor PR

[email protected]

KEYWORD: TEXAS UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: MOBILE/WIRELESS GENERAL HEALTH ONLINE RETAIL FAMILY CONSUMER MEDICAL DEVICES TECHNOLOGY PARENTING RETAIL BABY/MATERNITY WOMEN HEALTH

SOURCE: Inito

Copyright Business Wire 2026.

PUB: 04/09/2026 12:29 PM/DISC: 04/09/2026 12:30 PM

http://www.businesswire.com/news/home/20260409655970/en